The JI
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     
 


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Gebe, J. A.
Right arrow Articles by Buckner, J. H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gebe, J. A.
Right arrow Articles by Buckner, J. H.
The Journal of Immunology, 2001, 167: 3250-3256.
Copyright © 2001 by The American Association of Immunologists

T Cell Selection and Differential Activation on Structurally Related HLA-DR4 Ligands1

John A. Gebe*, Erik J. Novak*,{dagger}, William W. Kwok*, Andy G. Farr*,{ddagger}, Gerald T. Nepom*,{ddagger} and Jane H. Buckner2,*,§

* Benaroya Research Institute, Virginia Mason Research Center, Seattle, WA 98101; and {dagger} R. H. Williams Laboratory and Molecular and Cellular Biology Program, and Departments of {ddagger} Immunology and § Rheumatology, University of Washington School of Medicine, Seattle, WA 98101

Plasticity of TCR interactions during CD4+ T cell activation by an MHC-peptide complex accommodates variation in the peptide or MHC contact sites in which recognition of an altered ligand by the T cell can modify the T cell response. To explore the contribution of this form of TCR cross-recognition in the context of T cell selection on disease-associated HLA molecules, we have analyzed the relationship between TCR recognition of the DRB1*0401- and DRB1*0404-encoded HLA class II molecules associated with rheumatoid arthritis. Thymic reaggregation cultures demonstrated that CD4+ T cells selected on either DRB1*0401 or DRB1*0404 could be subsequently activated by the other MHC molecule. Using HLA tetramer technology we identify hemagglutinin residue 307–319-specific T cells restricted by DRB1*0401, but activated by hemagglutinin residues 307–319, in the context of DRB1*0404. One such clone exhibits an altered cytokine profile upon activation with the alternative MHC ligand. This altered phenotype persists when both class II molecules are present. These findings directly demonstrate that T cells selected on an MHC class II molecule carry the potential for activation on altered self ligands when encountering Ags presented on a related class II molecule. In individuals heterozygous for these alleles the possibility of TCR cross-recognition could lead to an aberrant immune response.




This article has been cited by other articles:


Home page
Int ImmunolHome page
Y. Watanabe, T. Takahashi, A. Okajima, M. Shiokawa, N. Ishii, I. Katano, R. Ito, M. Ito, M. Minegishi, N. Minegishi, et al.
The analysis of the functions of human B and T cells in humanized NOD/shi-scid/{gamma}cnull (NOG) mice (hu-HSC NOG mice)
Int. Immunol., July 1, 2009; 21(7): 843 - 858.
[Abstract] [Full Text] [PDF]


Home page
J. Immunol.Home page
N. A. Danke and W. W. Kwok
HLA Class II-Restricted CD4+ T Cell Responses Directed Against Influenza Viral Antigens Postinfluenza Vaccination
J. Immunol., September 15, 2003; 171(6): 3163 - 3169.
[Abstract] [Full Text] [PDF]


Home page
J. Virol.Home page
L. BenMohamed, G. Bertrand, C. D. McNamara, H. Gras-Masse, J. Hammer, S. L. Wechsler, and A. B. Nesburn
Identification of Novel Immunodominant CD4+ Th1-Type T-Cell Peptide Epitopes from Herpes Simplex Virus Glycoprotein D That Confer Protective Immunity
J. Virol., September 1, 2003; 77(17): 9463 - 9473.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Website Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.
All Contents Copyright © 2001 by The American Association of Immunologists, Inc. All rights reserved.